Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01933815
Title Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cortice Biosciences, Inc.
Indications

glioblastoma

Therapies

Bevacizumab

TPI 287

Age Groups: adult
Covered Countries USA


No variant requirements are available.